Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-25-001889
Filing Date
2025-01-13
Accepted
2025-01-13 11:39:27
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 2541344
2 ex31-1.htm EX-31.1 18700
3 ex31-2.htm EX-31.2 19487
4 ex32.htm EX-32 10978
5 aud_1.jpg GRAPHIC 11371
6 logo_1.jpg GRAPHIC 19012
  Complete submission text file 0001493152-25-001889.txt   11860754

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bixt-20231231.xsd EX-101.SCH 71683
8 XBRL CALCULATION FILE bixt-20231231_cal.xml EX-101.CAL 77386
9 XBRL DEFINITION FILE bixt-20231231_def.xml EX-101.DEF 337236
10 XBRL LABEL FILE bixt-20231231_lab.xml EX-101.LAB 478431
11 XBRL PRESENTATION FILE bixt-20231231_pre.xml EX-101.PRE 433635
90 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 2347963
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35027 | Film No.: 25525452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)